Related products

• 

  wishlist

  CLOSUREFAST

  ClosureFast™ 
  procedure

  Minimally invasive thermal
  treatment for vein disease
  and varicose veins.
  The ClosureFast procedure uses radiofrequency energy or heat to close the diseased vein, which redirects blood flow to healthy veins, relieving symptoms.

  Before the procedure

  You will have an ultrasound imaging exam of the leg being treated. This exam is important for assessing the diseased superficial vein and planning the procedure.

  During the procedure

  Your doctor will discuss the procedure with you. Here is a brief summary of what to expect:

  • The ClosureFast procedure is performed on an outpatient basis. Your doctor will perform the ClosureFast procedure. Using an ultrasound, your doctor will position a catheter in the diseased vein through a small opening in the skin.
  • The small catheter delivers heat to the vein wall, causing it to shrink and seal the vein. Once the diseased vein is closed, blood will reroute itself to other healthy veins.

  After the procedure

  • You will be taken to the recovery area to rest.
  • Following the procedure, your doctor will apply a simple bandage over the insertion site and will give you compression stockings to aid in the healing process. Your doctor may encourage you to walk and to refrain from extended standing and strenuous activities for a period of time. The average patient typically resumes normal activities within a few days.^1,2
  • Your doctor will recommend follow-up care as needed.

  • Benefits of the ClosureFast procedure

    • Relief of symptoms after two days, with a noticeable improvement in one to two week
    • Minimally invasive outpatient procedure
    • Less pain and bruising than laser treatment
    • Faster recovery than laser treatment
    • Proven results with positive patient experience

     

    • Rapid recovery — on average, patients resume normal activities within a few days
    • Lasting results — the only radiofrequency energy procedure with published long-term clinical data demonstrating safety and efficacy, with a 91.9% closure rate at five years.⁴

    Adverse events can include nerve injury, hematoma, phlebitis, thrombosis, and/or pulmonary embolism.

    Type of therapy
    Thermal shrinkage of the vein wall with radiofrequency energy or heat

    Inpatient or outpatient procedure
    Outpatient procedure

    One- versus two-leg treatment
    Typically, each leg will be treated in separate appointments

    Needle sticks required
    One needle stick for vein access. Typically, 5 to 10 needle sticks for anesthesia.

     

    Typical post-treatment recovery
    Healing of vein access site, anesthetic needle stick sites, and also healing of ablated vein section

    Compression hose
    Required for approximately one week

    Procedure success rate
    91.9% after five years⁴

    ---

    ClosureFast procedure FAQ

    Is the ClosureFast procedure painful?

    Most patients report feeling little, if any, pain during the ClosureFast procedure.³ Your doctor will give you a local or regional anesthetic to numb the treatment area.

    When can I return to normal activity?

    Patients treated with the ClosureFast procedure may resume normal activity more quickly than patients who undergo surgical vein stripping or laser ablation. With the ClosureFast procedure, the average patient typically resumes normal activity within a few days.² For a few weeks following the treatment, your vein specialist may recommend a regular walking regimen and suggest you refrain from strenuous activities (heavy lifting, for example) or prolonged periods of standing.

    When will my symptoms improve?

    Most patients report relief of symptoms after two days, with a noticeable improvement in one to two weeks.

    Is there any scarring, bruising, or swelling after the procedure?

    Most patients report limited to no scarring, bruising, or swelling following the ClosureFast procedure.³

    How is the ClosureFast procedure different from endovenous lasers?

    Both Closure Fast and lasers use thermal technology to deliver heat into the diseased vein, but they each use a different method of delivery. Despite their similarity in using heat, a 2009 study showed that the ClosureFast procedure is associated with lower rates of pain, bruising, and complications and a faster improvement in patients’ quality of life when compared to 980 nm laser ablation.⁴

    How is the Closure Fast procedure different from vein stripping?

    During vein stripping, incisions are made in the groin and calf, and a tool is threaded through the diseased vein to pull the vein out of the leg. With the ClosureFast procedure, only one small incision is made at the insertion site and the vein is then treated and left in place. ClosureFast is a minimally invasive approach that reduces the likelihood of pain and bruising, associated with vein stripping surgery.¹

    Is the ClosureFast procedure covered by insurance?

    Many patients have access to the ClosureFast procedure through their insurance coverage plan. Insurance companies detail access to the ClosureFast procedure and other radiofrequency ablation procedures in coverage policies for varicose veins or chronic venous insufficiency. As with all healthcare procedures, you may also have some cost associated with receiving treatment, such as a copay or coinsurance. Please reach out to your insurance company to discuss your specific plan coverage and potential costs prior to seeking treatment

• 

  Rated 1.00 out of 5

  wishlist

  PROGREAT® MICROCATHETHER

  PRODUCT OVERVIEW

  PROGREAT^® Microcatheters are designed to allow navigation through tortuous peripheral vessels for optimal access and delivery of therapeutic embolization.

  Terumo Progreat 2.7Fr. Microcatheter is Designed to provide optimal trackability and support even in the most tortuous anatomy.

  DESIGNED TO CONFIDENTLY DELIVER EMBOLOTHERAPY

  • Tungsten coil reinforcement for kink resistance²
  • PTFE inner layer is designed for exceptional guidewire tracking, with virtually frictionless delivery of coils and other embolics²
  • DMSO Compatible³ 
  • Radiopaque 0.7 mm platinum/iridium markers allow for rapid and precise positioning⁴

  

  DESIGNED TO ENHANCE ACCESS TO SMALL PERIPHERAL VESSELS

  • TERUMO Glide Technology^TM hydrophilic coating enhances navigation through tortuous anatomy^1,2
  • Unique varied tungsten coil pitch construction provides distal flexibility and proximal pushability, enhancing vessel selectivity and catheter placement.

  

  PROGREAT® COAXIAL MICROCATHETER SYSTEM

  • Preloaded with uniquely designed 0.021” GLIDEWIRE^® GT for the 2.8Fr system and 0.018″ GLIDEWIRE^® GT for the 2.4Fr system¹
  • Available in 2.8Fr and 2.4Fr
  • Enables simultaneous preparation of microcatheter and guidewire, which may save time and increase procedural efficiency¹ 

  PROGREAT 2.4 COAXIAL PROVEN TO REACH DISTAL VESSELS WITH EASE⁴

  • Provides greater vessel selectivity and demonstrated superiority in traversing tortuous anatomy
  • Provides best-in-class kink resistance, demonstrated in both the distal and proximal shaft.

  

  PROGREAT® Microcatheter Product Codes

  Includes hemostatic valve and shaping mandrel

  Fr Size	Product Code	Length (cm)	Tip Shape	Max Pressure (psi)	RO Markers	Hydrophilic Coating Length (cm)
  2.4	MC*PB2411Y	110	Straight	750	1	50
  	MC*PB2413Y	130	Straight		1	70
  	MC*PB2413ZRA	130	70 Deg. Angle		1	70
  	MC*PB2413ZRC	130	J Curve		1	70
  	MC*PV2415Y	150	Straight		2	90
  	MC*PV2415ZRA	150	70 Deg. Angle		2	90
  	MC*PV2415ZRC	150	J Curve		2	90
  2.7	MC*PC2711Y	110	Straight	750	–	50
  	MC*PC27137	130	Straight		–	70
  2.8	MC*PB2811Y	110	Straight	900	1	50
  	MC*PB2813Y	130	Straight		1	70
  	MC*PV2815Y	150	Straight		2	90

  PROGREAT^® Coaxial Microcatheter System Codes

  Includes unique GLIDEWIRE® GT Guidewire, wire stopper, guidewire introducer, hemostatic valve, 2.5 mL syringe, and shaping mandrel

  Fr Size	Product Code	Length (cm)	Max Pressure (PSI)	RO Markers	Hydrophilic Coating Length (cm)	Glidewire® GT Length (cm)	Glidewire® GT Size (in)
  2.4 Fr	MC*PE24111YB	110	750	1	50	120	0.018
  2.4 Fr	MC*PE24131YB	130	750	1	70	140	0.018
  2.4 Fr	MC*PE24151YV	150	750	2	90	160	0.018
  2.7 Fr	MC*PE27111Y	110	750	–	50	120	0.021
  2.7 Fr	MC*PE27131Y	130	750	–	70	140	0.021
  2.8 Fr	MC*PE28111YB	110	900	1	50	120	0.021
  2.8 Fr	MC*PE28131YB	130	900	1	70	140	0.021
  2.8 Fr	MC*PE28151YV	150	900	2	90	160	0.021

  PRODUCT SPECIFICATIONS

  Catheter OD	Length (cm)	Inner Diameter (in/mm)	Max GW (in)	Embolic Compatibility	Dead Space Volume (mL)	Actual Flow Rate* (mL/sec) @ 750 psi	Actual Flow Rate* (mL/sec) @ 900 psi
  2.4/2.9Fr (0.80/0.97mm)	110	0.022″/0.57	0.018″	0.018″ Coils/HydroPearl® 600 ± 75 μm	0.48	2.3	–
  2.4/2.9Fr (0.80/0.97mm)	130	0.022″/0.57	0.018″	0.018″ Coils/HydroPearl® 600 ± 75 μm	0.53	2	–
  2.4/2.9Fr (0.80/0.97mm)	150	0.022″/0.57	0.018″	0.018″ Coils/HydroPearl® 600 ± 75 μm	0.58	1.8	–
  2.7/2.9Fr (0.90/0.97mm)	110	0.025″/0.065	0.021″	0.018″ Coils/HydroPearl® 800 ± 75 μm	0.57	3.5	–
  2.7/2.9Fr (0.90/0.97mm)	130	0.025″/0.065	0.021″	0.018″ Coils/HydroPearl® 800 ± 75 μm	0.64	3.2	–
  2.8/3.0Fr (0.93/1.00mm)	110	0.027″/0.70	0.021″	0.018″ Coils/HydroPearl® 800 ± 75 μm	0.61	4.1	4.7
  2.8/3.0Fr (0.93/1.00mm)	130	0.027″/0.70	0.021″	0.018″ Coils/HydroPearl® 800 ± 75 μm	0.68	3.7	4.3
  2.8/3.0Fr (0.93/1.00mm)	150	0.027″/0.70	0.021″	0.018″ Coils/HydroPearl® 800 ± 75 μm	0.75	3.1	3.9

  REFERENCES

  RX ONLY. Refer to the product labels and package insert for complete warnings, precautions, potential complications, and instructions for use.

  1. Catheter [Instructions for Use]. Somerset, NJ: Terumo Medical Corporation; 2016
  2. PROGREAT Catheter 510(k); 2003
  3. PROGREAT DMSO Compatibility Statement Letter
  4. Data on file.
• 

  wishlist

  FINECROSS Microcatheter

  FINECROSS^® MG Coronary Micro-Guide Catheter

  Product Code	Catheter Length	Distal Hydrophilic Coating	Distal Outer Diameter	Proximal Outer Diameter	Distal Inner Diameter	Proximal Inner Diameter	Recommended Guidewire Size
  35-1430	130cm	70cm	1.8Fr. (0.60mm)	2.6 Fr. (0.87mm)	0.018″ (0.45mm)	0.021″ (0.55mm)	0.014″ (0.36mm)
  35-1450	150cm	90cm	1.8Fr. (0.60mm)	2.6 Fr. (0.87mm)	0.018″ (0.45mm)	0.021″ (0.55mm)	0.014″ (0.36mm)

  PRODUCT OVERVIEW

  Coronary microguide catheter for integration of optimal guidewire support, superior trackability and crossability.^1,2

  

  TAPERED STAINLESS STEEL BRAID CONSTRUCTION FOR OPTIMAL GUIDEWIRE SUPPORT

  FINECROSS MG stainless steel braid construction is designed to provide strength, responsiveness and support for improved pushability to access and cross complex lesions.

  13cm FLOPPY DISTAL SEGMENT FOR SUPERIOR TRACKABILITY¹

  The distal 13 cm is ultra flexible for improved trackability around tight bends and tortuous anatomy.The floppy distal segment is designed to be atraumatic and provide an optimal balance between trackability and safety while navigating through the tortuous anatomy.¹

  TAPERED OUTER DIAMETER FOR SUPERIOR CROSSABILITY^1,2

  The outer diameter of the stainless steel shaft tapers from a proximal 2.6Fr. to a distal 1.8Fr. designed for improved crossability and guidewire handling.^1,2

  DOCUMENTS

• 

  Rated 4.00 out of 5

  wishlist

  PTCA Balloon Ryurei

  Description

  Confidence in your hands

  Ryurei™ has superior crossability¹ thanks to the combination of low distal profiles and Terumo’s hydrophilic M coating. The short balloon bonding and reinforced shaft¹ results in enhanced trackability¹ while maintaining excellent pushability¹.

  These features can increase physician’s confidence in success even during complex procedures.

  Characteristics

  Excellent Pusability

  The combination of flexible distal part,  tapered core wire on the midshaft and the thick proximal hypotube, results in smooth and balanced transition across the entire catheter for high transmission force, resulting in excellent pushability

  Superior Crossability²

  Thanks to the combination of distal  low profiles and the Terumo hydrophilic M-Coat, Ryurei offers low friction in crossing tight lesions

  Enhanced Trackability²

  With an optimal tip design and improved balloon bonding, Ryurei provides enhanced trackability, even in tortuous anatomy and difficult to navigate vessels.

  

   

  General specifications

  ​Shaft diameter	​1.9 Fr/0.64 mm Proximal • 2.5 Fr/0.84 mm Middle • 2.4 Fr/0.79 mm to 2.7 Fr/0.89 mm (tapered) Distal (1.00 to 1.50 mm) • 2.6 Fr/0.87 mm Distal (2.00 to 4.00 mm)
  ​Usable length	​145 cm
  ​Balloon markers #	​1(Ø1.0 to Ø 1.5 mm) • 2(Ø2.0 to Ø4.0 mm)
  ​Nominal pressure	​6 atm / 608 kPa
  ​Rated burst pressure	Ø1.0 – 3.0 mm=14 atm(1419kPa) • Ø3.25 – 4.0 mm = 12 atm(1216 kPa)
  ​Guidewire compatibility	​Maximum diameter: 0.014″ / 0.36 mm
  ​Lesion entry profile	​0.41 mm (Ø1.00 to Ø1.50 mm) • 0.43 mm (Ø2.00 to Ø4.00 mm)
  ​Coating	​Hydrophilic

  Item specifications

  Balloon length / Product code​ ​ ​ ​ ​ ​ ​
  Balloon Diameter	5 mm	10 mm	15 mm	20 mm	30 mm	40 mm
  1.00 mm	DC-RR1005HH
  ​1.25 mm	​DC-RR1205HH	​​DC-RR1210HH	​​DC-RR1215HH	​​DC-RR1220HH	​	​
  1.50 mm	DC-RR1505HH	DC-RR1510HH	DC-RR1515HH	DC-RR1520HH
  2.00 mm		DC-RR2010HHW	DC-RR2015HHW	DC-RR2020HHW	DC-RR2030HHW	DC-RR2040HHW
  2.25 mm		DC-RR2210HHW	DC-RR2215HHW	DC-RR2220HHW
  2.50 mm		DC-RR2510HHW	DC-RR2515HHW	DC-RR2520HHW	DC-RR2530HHW	DC-RR2540HHW
  2.75 mm		DCRR2710HHW	DC-RR2715HHW	DC-RR2720HHW
  3.00 mm		DC-RR3010HHW	DC-RR3015HHW	DC-RR3020HHW	DC-RR3030HHW	DC-RR3040HHW
  3.25 mm		DC-RR3210HHW	DC-RR3215HHW	DC-RR3220HHW
  3.50 mm		DC-RR3510HHW	DC-RR3515HHW	DC-RR3520HHW	DC-RR3530HHW	DC-RR3540HHW
  3.75 mm		DC-RR3710HHW	DC-RR3715HHW	DC-RR3720HHW
  4.00 mm		DC-RR4010HHW	DC-RR4015HHW	DC-RR4020HHW

  References

  ¹ Ryurei φ1.00-5mm compared to Tazuna 1.25-10 mm- Data on file ISCD-416-31-4
  * For Ryurei Ø 1.00 mm – Ø 1.50 mm.
  ** For Ryurei Ø 1.00mm – 5mm ​

   

  ² Compared to Tazuna PTCA dilatation catheter